Bioorganic and Medicinal Chemistry Letters p. 2319 - 2323 (2001)
Update date:2022-07-30
Topics:
Kawahata, Noriyuki
Yang, Michael G.
Luke, George P.
Shakespeare, William C.
Sundaramoorthi, Raji
Wang, Yihan
Johnson, Daniel
Merry, Taylor
Violette, Shelia
Guan, Wei
Bartlett, Catherine
Smith, Jeremy
Hatada, Marcos
Lu, Xiaode
Dalgarno, David C.
Eyermann, Charles J.
Bohacek, Regine S.
Sawyer, Tomi K.
The novel phosphotyrosine (pTyr) mimetic 4′-carboxymethyloxy-3′-phosphonophenylalanine (Cpp) has been designed and incorporated into a series of nonpeptide inhibitors of the SH2 domain of pp60c-Src (Src) tyrosine kinase. A 2.2 A X-ray crystal structure of 1a bound to a mutant form of Lck SH2 domain provides insight regarding the structure-activity relationships and supports the design concept of this new pTyr mimetic.
View MoreContact:+86-570-4336358
Address:No.87 Building,Tianqian,Sidu Town
Henan PURUI Pharmaceutical Co., Ltd.
website:http://www.puruipharm.com
Contact:17739583555
Address:Yezhuangqiao,Xihua town, Henan province
Zhejiang Genebest Pharmaceutical Co.,Ltd.
Contact:0086-571-63532866
Address:No.1 Jinboshi Rd Lishan Town Fuyang City Zhejiang Province China
Shijiazhuang Sdyano Fine Chemical Co., Ltd
Contact:+86-311-89830448
Address:NO.48 Ta Nan Road,Yuhua District,Shijiazhuang,Hebei,China
Jiangsu Fengshan Group Co., Ltd.
Contact:86-25-86558671
Address:1903,Central International Mansion 105-6 North Zhongshan Road, Nanjing, China
Doi:10.1016/j.tetlet.2005.01.008
(2005)Doi:10.1002/1521-3773(20010401)40:7<1235::AID-ANIE1235>3.0.CO;2-Y
(2001)Doi:10.1055/s-1972-21953
(1972)Doi:10.3184/174751916X14760947474916
(2016)Doi:10.1016/j.tet.2006.06.088
(2006)Doi:10.1039/jr9510003009
(1951)